Company Filing History:
Years Active: 2006
Title: Innovations of Irene Lagoja in HIV Research
Introduction
Irene Lagoja is a notable inventor based in Leuven, Belgium. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit HIV. Her work is characterized by a strong focus on biological activity against viral infections.
Latest Patents
Irene Lagoja holds a patent for "HIV inhibiting N-aminoimidazole derivatives." This invention includes an N-aminoimidazole or N-aminoimidazolethione derivative, which can be represented by a specific general formula. The patent describes various forms of the compound, including pharmaceutically acceptable salts, tautomers, isomers, esters, or glycosylation products. The compounds are designed to have biological activity, especially against viral infections, making them valuable in the fight against HIV. She has 1 patent related to this innovative work.
Career Highlights
Irene Lagoja is affiliated with K.U. Leuven Research & Development, where she has been involved in groundbreaking research. Her career is marked by a commitment to advancing medical science through innovative solutions.
Collaborations
Irene has collaborated with esteemed colleagues such as Erik De Clercq and Arthur Van Aerschot. These partnerships have further enhanced her research and contributed to the development of effective antiviral agents.
Conclusion
Irene Lagoja's contributions to HIV research through her innovative patents highlight her role as a leading inventor in the pharmaceutical field. Her work continues to inspire advancements in the treatment of viral infections.